Using migraine medicines to treat Meniere’s disease symptoms
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This Phase 4 study tests whether migraine-type medications can help people with active or frequent Meniere’s disease. If you have symptoms like inner-ear episodes, the trial may help find a better way to control them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active or frequent Meniere’s disease symptoms
- You are between 25 and 85 years old
- You can reliably take the study medication and come to study visits
- You can read and write in English for consent and study forms
- If you can get pregnant, you must pass a pregnancy test (pregnancy means you cannot join)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two types of migraine prevention medicines—standard preventive therapies versus newer anti-CGRP treatments—can help reduce tinnitus (ringing or buzzing in the ears) in people who also have migraines. If you have both conditions, this trial may help find a treatment that eases your ear symptoms.
This Phase 3 study compares injections of steroid medicine into the ear versus a dummy (placebo) injection to see if it reduces vertigo attacks in people with Ménière’s disease. It may help by improving balance symptoms and reducing how often attacks happen.
This trial tests an oral liquid medication called isosorbide to see if it can reduce vertigo episodes in people with Meniere's disease. The study will compare its effects against a placebo to confirm if it's safe and helpful.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This trial compares two different first-time preventive treatments for migraine in a primary care setting. If you qualify, you'll receive one of the study medications, and the research team will track how well it reduces your migraine days.
This study compares two common medicines, nortriptyline and amitriptyline, to see which works better at preventing migraines. Both are antidepressants that are often used to stop migraines before they start.
Hear when a new Ménière trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.